SILDENAFIL CITRATE AFTER RADICAL RETROPUBIC PROSTATECTOMY

Autor:	Edward C. Schatte, Francisco J. Orejuela, Peter T. Scardino, Brian J. Miles, Edward D. Kim, Kevin M. Slawin, Benjamin H. Lowentritt, Sean P. Elliott
Rok vydání:	1999
Předmět:	medicine.medical_specialty business.industry Sildenafil Prostatectomy Urology medicine.medical_treatment medicine.disease Prostate-specific antigen chemistry.chemical_compound Erectile dysfunction chemistry medicine Stage (cooking) business Complication Pathological Radical retropubic prostatectomy
Zdroj:	Journal of Urology. 162:1614-1617
ISSN:	1527-3792 0022-5347
DOI:	10.1016/s0022-5347(05)68179-7
Popis:	Purpose:: Erectile dysfunction continues to be a significant problem for men after radical retropubic prostatectomy despite nerve sparing techniques. Sildenafil citrate (Viagra ‡ ‡Pfizer, New York, New York.) has proved effective for erectile dysfunction in many men. We determine the efficacy of sildenafil in men with erectile dysfunction after radical retropubic prostatectomy and examine variables that may impact the response to treatment.Materials and Methods:: A total of 84 men were prescribed sildenafil after radical retropubic prostatectomy and asked to complete a series of questionnaires, including the International Index of Erectile Function (IIEF), on erectile function before and after sildenafil administration. The importance of factors, such as patient age, time since surgery, degree of cavernous nerve sparing, preoperative prostate specific antigen, Gleason score, clinical and pathological stage, and baseline postoperative erectile function, was examined.Results:: Of the 84 patients 45 (53%) ha...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8216c02bca3bc43632b5abc1de9c6572 https://doi.org/10.1016/s0022-5347(05)68179-7 Zobrazit plný text záznamu